IN
INNOCAN PHARMA Corp
INNPF · OTC
$1.60 -8.05% (-$0.14)
1M +18.24%
Market Cap $7.20M
P/E Ratio -
Div. Yield -
ROE 13.58%
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap EV/EBITDA 1.14x
P/S 0.24x
P/B 1.71x
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
22 /100
Weak Gross margin 88.90%
Net margin 2.21%
Op. margin 1.22%
Quality
17 /100
Poor ROIC 1.93%
ROE 13.58%
ROA 5.95%
Debt
99 /100
Low Debt/Equity 0.33x
Current ratio 3.70x
Int. coverage 126.33x
Stability
50 /100
Moderate Beta -0.22x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about INNPF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Iris Bincovich
Employees
11
Headquarters
Calgary